2023 Q4 Form 10-Q Financial Statement

#000127618723000093 Filed on November 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $20.53B $20.74B
YoY Change 0.15% -9.59%
Cost Of Revenue $15.78B $16.06B
YoY Change -1.76% -13.27%
Gross Profit $4.752B $4.680B
YoY Change 7.08% 5.81%
Gross Profit Margin 23.14% 22.57%
Selling, General & Admin $285.0M $234.0M
YoY Change 31.94% -35.18%
% of Gross Profit 6.0% 5.0%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.158B $1.107B
YoY Change 9.25% 7.48%
% of Gross Profit 24.37% 23.65%
Operating Expenses $2.587B $234.0M
YoY Change -1.71% -35.18%
Operating Profit $2.165B $2.233B
YoY Change 19.88% 13.18%
Interest Expense -$600.0M $632.0M
YoY Change 12.99% 9.53%
% of Operating Profit -27.71% 28.3%
Other Income/Expense, Net $49.00M $13.00M
YoY Change -76.33% -110.83%
Pretax Income $1.614B $1.124B
YoY Change 8.91% -19.94%
Income Tax $47.00M $77.00M
% Of Pretax Income 2.91% 6.85%
Net Earnings $1.203B $584.0M
YoY Change 14.68% -41.95%
Net Earnings / Revenue 5.86% 2.82%
Basic Earnings Per Share
Diluted Earnings Per Share $0.37 $0.15
COMMON SHARES
Basic Shares Outstanding 3.145B shares 3.143B shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $161.0M $514.0M
YoY Change -37.35% 57.67%
Cash & Equivalents $161.0M $514.0M
Short-Term Investments
Other Short-Term Assets $513.0M $508.0M
YoY Change -29.34% -12.41%
Inventory $2.478B $2.590B
Prepaid Expenses
Receivables $9.047B $9.612B
Other Receivables $67.00M $84.00M
Total Short-Term Assets $12.43B $13.42B
YoY Change 2.91% 10.4%
LONG-TERM ASSETS
Property, Plant & Equipment $85.35B $80.87B
YoY Change 6.28% 0.76%
Goodwill $4.020B $2.564B
YoY Change 56.42% 0.43%
Intangibles $6.239B $5.204B
YoY Change 15.22% -5.47%
Long-Term Investments $3.097B $2.993B
YoY Change 7.05% 4.32%
Other Assets $1.733B $1.690B
YoY Change 11.23% 7.44%
Total Long-Term Assets $101.3B $94.15B
YoY Change 8.23% 0.61%
TOTAL ASSETS
Total Short-Term Assets $12.43B $13.42B
Total Long-Term Assets $101.3B $94.15B
Total Assets $113.7B $107.6B
YoY Change 7.62% 1.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.663B $7.997B
YoY Change -4.16% 6.43%
Accrued Expenses $3.577B $3.741B
YoY Change 6.02% -66.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.008B $1.006B
YoY Change 50300.0% 50200.0%
Total Short-Term Liabilities $11.28B $12.76B
YoY Change 8.77% 13.45%
LONG-TERM LIABILITIES
Long-Term Debt $51.38B $47.08B
YoY Change 6.46% -0.71%
Other Long-Term Liabilities $1.611B $2.016B
YoY Change 20.13% 31.76%
Total Long-Term Liabilities $52.99B $49.09B
YoY Change 6.83% 0.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.28B $12.76B
Total Long-Term Liabilities $52.99B $49.09B
Total Liabilities $64.27B $61.85B
YoY Change 7.17% 2.76%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $36.68B $33.12B
YoY Change
Total Liabilities & Shareholders Equity $113.7B $107.6B
YoY Change 7.62% 1.74%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $1.203B $584.0M
YoY Change 14.68% -41.95%
Depreciation, Depletion And Amortization $1.158B $1.107B
YoY Change 9.25% 7.48%
Cash From Operating Activities $1.296B $2.373B
YoY Change -3.14% -20.61%
INVESTING ACTIVITIES
Capital Expenditures $704.0M $701.0M
YoY Change -20.72% -167.73%
Acquisitions
YoY Change
Other Investing Activities -$260.0M $31.00M
YoY Change 356.14% -135.23%
Cash From Investing Activities -$964.0M -$670.0M
YoY Change 2.01% -40.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -685.0M -1.519B
YoY Change 48.27% -19.76%
NET CHANGE
Cash From Operating Activities 1.296B 2.373B
Cash From Investing Activities -964.0M -670.0M
Cash From Financing Activities -685.0M -1.519B
Net Change In Cash -353.0M 184.0M
YoY Change 411.59% -781.48%
FREE CASH FLOW
Cash From Operating Activities $1.296B $2.373B
Capital Expenditures $704.0M $701.0M
Free Cash Flow $592.0M $1.672B
YoY Change 31.56% -58.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3145065881 shares
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
257000000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9612000000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8466000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
2590000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2461000000 usd
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
84000000 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
68000000 usd
CY2023Q3 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
14000000 usd
CY2022Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
10000000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
508000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
726000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
12081000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
105996000000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
25685000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
80311000000 usd
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
2893000000 usd
CY2023Q3 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
4000000 usd
CY2022Q4 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
0 usd
CY2023Q3 et Lease Rightof Use Asset Net
LeaseRightofUseAssetNet
820000000 usd
CY2022Q4 et Lease Rightof Use Asset Net
LeaseRightofUseAssetNet
819000000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1690000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1558000000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5204000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5415000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
2564000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2566000000 usd
CY2023Q3 us-gaap Assets
Assets
107571000000 usd
CY2022Q4 us-gaap Assets
Assets
105643000000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7997000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6952000000 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4000000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
23000000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
45000000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3696000000 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Other Carrying Amount
RedeemableNoncontrollingInterestEquityOtherCarryingAmount
493000000 usd
CY2022Q4 us-gaap Preferred Units Preferred Partners Capital Accounts
PreferredUnitsPreferredPartnersCapitalAccounts
6051000000 usd
CY2022Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
26960000000 usd
CY2022Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
-2000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
16000000 usd
CY2022Q4 us-gaap Partners Capital
PartnersCapital
33025000000 usd
CY2022Q4 us-gaap Partners Capital Attributable To Noncontrolling Interest
PartnersCapitalAttributableToNoncontrollingInterest
7634000000 usd
CY2022Q4 us-gaap Partners Capital Including Portion Attributable To Noncontrolling Interest
PartnersCapitalIncludingPortionAttributableToNoncontrollingInterest
40659000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
105643000000 usd
CY2023Q3 us-gaap Revenues
Revenues
20739000000 usd
CY2022Q3 us-gaap Revenues
Revenues
22939000000 usd
us-gaap Revenues
Revenues
58054000000 usd
us-gaap Revenues
Revenues
69375000000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16059000000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18516000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
44761000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
56169000000 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1105000000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1030000000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3227000000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3104000000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
234000000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
361000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
700000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
802000000 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1000000 usd
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
86000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
12000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
386000000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
18506000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
63443000000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2233000000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1973000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
6130000000 usd
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
47000000 usd
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
303000000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P0Y3M
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y3M
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P2Y3M
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y3M
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
514000000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
45000000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3329000000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1006000000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10368000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
48260000000 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
23000000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
798000000 usd
CY2022Q4 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
3701000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1341000000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
973000000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
3224000000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2982000000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1107000000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
20966000000 usd
us-gaap Costs And Expenses
CostsAndExpenses
51924000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
5932000000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
632000000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
577000000 usd
us-gaap Interest Expense
InterestExpense
1892000000 usd
us-gaap Interest Expense
InterestExpense
1714000000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
103000000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
68000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
286000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
186000000 usd
CY2023Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-625000000 usd
CY2022Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-625000000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
CY2023Q3 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
466000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
1322000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
0 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
0 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
13000000 usd
CY2023Q3 et Changeinothercomprehensiveincomefromequityinvestments
Changeinothercomprehensiveincomefromequityinvestments
3000000 usd
CY2022Q3 et Changeinothercomprehensiveincomefromequityinvestments
Changeinothercomprehensiveincomefromequityinvestments
6000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1052000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1337000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
451000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
307000000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
12000000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
12000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
589000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1018000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40659000000 usd
CY2023Q1 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
1001000000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
441000000 usd
CY2023Q1 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
3000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3000000 usd
CY2023Q1 us-gaap Partners Capital Other
PartnersCapitalOther
18000000 usd
CY2023Q1 et Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Portion Attributableto Redeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingPortionAttributabletoRedeemableNoncontrollingInterest
1434000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40669000000 usd
CY2023Q2 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
1094000000 usd
CY2023Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
421000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000000 usd
CY2023Q2 us-gaap Partners Capital Account Acquisitions
PartnersCapitalAccountAcquisitions
574000000 usd
CY2023Q2 us-gaap Partners Capital Other
PartnersCapitalOther
14000000 usd
CY2023Q2 et Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Portion Attributableto Redeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingPortionAttributabletoRedeemableNoncontrollingInterest
1219000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40962000000 usd
CY2023Q3 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
1029000000 usd
CY2023Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
428000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5000000 usd
CY2023Q3 us-gaap Partners Capital Other
PartnersCapitalOther
16000000 usd
CY2023Q3 et Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Portion Attributableto Redeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingPortionAttributabletoRedeemableNoncontrollingInterest
1035000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40561000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39345000000 usd
CY2022Q1 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
608000000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
307000000 usd
CY2022Q1 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
373000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25000000 usd
CY2022Q1 us-gaap Partners Capital Other
PartnersCapitalOther
27000000 usd
CY2022Q1 et Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Portion Attributableto Redeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingPortionAttributabletoRedeemableNoncontrollingInterest
1474000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40329000000 usd
CY2022Q2 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
735000000 usd
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
446000000 usd
CY2022Q2 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
24000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-28000000 usd
CY2022Q2 us-gaap Partners Capital Other
PartnersCapitalOther
11000000 usd
CY2022Q2 et Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Portion Attributableto Redeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingPortionAttributabletoRedeemableNoncontrollingInterest
1610000000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40765000000 usd
CY2022Q3 us-gaap Partners Capital Account Distributions
PartnersCapitalAccountDistributions
775000000 usd
CY2022Q3 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
424000000 usd
CY2022Q3 us-gaap Partners Capital Account Contributions
PartnersCapitalAccountContributions
7000000 usd
CY2022Q3 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
346000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
15000000 usd
CY2022Q3 us-gaap Partners Capital Other
PartnersCapitalOther
16000000 usd
CY2022Q3 et Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Portion Attributableto Redeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingPortionAttributabletoRedeemableNoncontrollingInterest
1310000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40568000000 usd
us-gaap Profit Loss
ProfitLoss
3727000000 usd
us-gaap Profit Loss
ProfitLoss
4431000000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3227000000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3104000000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-187000000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-158000000 usd
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
-113000000 usd
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
-81000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
99000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
88000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
12000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
386000000 usd
et Distributions On Unvested Unit Awards
DistributionsOnUnvestedUnitAwards
47000000 usd
et Distributions On Unvested Unit Awards
DistributionsOnUnvestedUnitAwards
37000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
286000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
186000000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
286000000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
182000000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
15000000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
120000000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
-1182000000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
212000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8259000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7713000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
111000000 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1062000000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2430000000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2493000000 usd
us-gaap Proceeds From Contribution In Aid Of Construction
ProceedsFromContributionInAidOfConstruction
38000000 usd
us-gaap Proceeds From Contribution In Aid Of Construction
ProceedsFromContributionInAidOfConstruction
50000000 usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
5000000 usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
0 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
45000000 usd
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
66000000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
302000000 usd
us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
31000000 usd
us-gaap Proceeds From Sale Of Other Assets Investing Activities
ProceedsFromSaleOfOtherAssetsInvestingActivities
60000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3361000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3077000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
22912000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
19400000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
23095000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
21110000000 usd
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
3000000 usd
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
404000000 usd
us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
3124000000 usd
us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
2118000000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1290000000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1177000000 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
37000000 usd
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
37000000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
12000000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
9000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
2000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4641000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4646000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
257000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
257000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
336000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
514000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
326000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited consolidated financial statements have been prepared in conformity with GAAP, which requires the use of estimates and assumptions made by management that affect the reported amounts of assets, liabilities, revenues, expenses and the accrual for and disclosure of contingent assets and liabilities that exist at the date of the consolidated financial statements. Although these estimates are based on management’s available knowledge of current and expected future events, actual results could be different from those estimates.</span></div>
CY2023Q2 us-gaap Equity Issued In Business Combination Fair Value Disclosure
EquityIssuedInBusinessCombinationFairValueDisclosure
574000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
48260000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
999000000 usd
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-17000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
287000000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
176000000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-106000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
599000000 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
1000000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
585000000 usd
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
254000000 usd
us-gaap Increase Decrease In Risk Management Assets And Liabilities
IncreaseDecreaseInRiskManagementAssetsAndLiabilities
312000000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
212000000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
454000000 usd
et Rightof Use Assets Obtainedin Exchangefor Liabilities
RightofUseAssetsObtainedinExchangeforLiabilities
37000000 usd
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
42000000 usd
CY2023Q3 us-gaap Energy Related Inventory Natural Gas In Storage
EnergyRelatedInventoryNaturalGasInStorage
1951000000 usd
CY2022Q4 us-gaap Energy Related Inventory Natural Gas In Storage
EnergyRelatedInventoryNaturalGasInStorage
1802000000 usd
CY2023Q3 us-gaap Inventory Crude Oil Products And Merchandise
InventoryCrudeOilProductsAndMerchandise
169000000 usd
CY2022Q4 us-gaap Inventory Crude Oil Products And Merchandise
InventoryCrudeOilProductsAndMerchandise
246000000 usd
CY2023Q3 us-gaap Other Inventory Supplies
OtherInventorySupplies
470000000 usd
CY2022Q4 us-gaap Other Inventory Supplies
OtherInventorySupplies
413000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
2590000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2461000000 usd
CY2023Q3 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
-141000000 usd
CY2022Q3 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
40000000 usd
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
-113000000 usd
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
-81000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0 usd
CY2023Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
44600000000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
48080000000.00 usd
CY2022Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
45420000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
1047000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
1322000000 usd
us-gaap Profit Loss
ProfitLoss
3727000000 usd
us-gaap Profit Loss
ProfitLoss
4431000000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
451000000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
304000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1080000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
793000000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
12000000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
12000000 usd
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
39000000 usd
us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
37000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
584000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
1006000000 usd
us-gaap Net Income Loss
NetIncomeLoss
2608000000 usd
us-gaap Net Income Loss
NetIncomeLoss
3601000000 usd
CY2023Q3 us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
0 usd
CY2022Q3 us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
-1000000 usd
us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
-2000000 usd
us-gaap Net Income Loss Allocated To General Partners
NetIncomeLossAllocatedToGeneralPartners
-3000000 usd
CY2023Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
118000000 usd
CY2022Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
106000000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
340000000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
317000000 usd
CY2023Q3 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
466000000 usd
CY2022Q3 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
899000000 usd
us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
2266000000 usd
us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
3281000000 usd
CY2023Q3 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
3144000000 shares
CY2022Q3 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
3087600000 shares
us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
3122300000 shares
us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
3085600000 shares
CY2023Q3 us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
0.15
CY2022Q3 us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
0.29
us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
0.73
us-gaap Net Income Loss Per Outstanding Limited Partnership Unit Basic Net Of Tax
NetIncomeLossPerOutstandingLimitedPartnershipUnitBasicNetOfTax
1.06
CY2023Q3 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
466000000 usd
CY2022Q3 us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
899000000 usd
us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
2266000000 usd
us-gaap Net Income Loss Allocated To Limited Partners
NetIncomeLossAllocatedToLimitedPartners
3281000000 usd
CY2023Q3 us-gaap Dilutive Securities
DilutiveSecurities
-1000000 usd
CY2022Q3 us-gaap Dilutive Securities
DilutiveSecurities
0 usd
us-gaap Dilutive Securities
DilutiveSecurities
-2000000 usd
us-gaap Dilutive Securities
DilutiveSecurities
-2000000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
465000000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
899000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2264000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3279000000 usd
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
23700000 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
21000000.0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
23600000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
20800000 shares
CY2023Q3 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
3167700000 shares
CY2022Q3 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
3108600000 shares
us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
3145900000 shares
us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
3106400000 shares
CY2023Q3 us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
0.15
CY2022Q3 us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
0.29
us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
0.72
us-gaap Net Income Loss Net Of Tax Per Outstanding Limited Partnership Unit Diluted
NetIncomeLossNetOfTaxPerOutstandingLimitedPartnershipUnitDiluted
1.06
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
813000000 usd
CY2023Q3 us-gaap Supplementary Leverage Ratio
SupplementaryLeverageRatio
3.11
CY2022Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
3094400000 shares
us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
5500000 shares
us-gaap Partners Capital Account Units Unitbased Compensation
PartnersCapitalAccountUnitsUnitbasedCompensation
700000 shares
CY2023Q3 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
3145100000 shares
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
880000000 usd
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
70000000 usd
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
70000000 usd
CY2023Q3 et Common Units Remaining Availabletobe Issued Under Distribution Reinvestment Plan
CommonUnitsRemainingAvailabletobeIssuedUnderDistributionReinvestmentPlan
6000000 shares
CY2022Q4 us-gaap Distribution Made To Limited Partner Distributions Paid Per Unit
DistributionMadeToLimitedPartnerDistributionsPaidPerUnit
0.3050
CY2023Q1 us-gaap Distribution Made To Limited Partner Distributions Paid Per Unit
DistributionMadeToLimitedPartnerDistributionsPaidPerUnit
0.3075
CY2023Q2 us-gaap Distribution Made To Limited Partner Distributions Paid Per Unit
DistributionMadeToLimitedPartnerDistributionsPaidPerUnit
0.3100
CY2023Q3 us-gaap Distribution Made To Limited Partner Distributions Paid Per Unit
DistributionMadeToLimitedPartnerDistributionsPaidPerUnit
0.3125
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
347000000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
11000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
9000000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
6000000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1000000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-7000000 usd
us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-7000000 usd
CY2023Q3 et Aoci Attributable To Equity Method Investments
AociAttributableToEquityMethodInvestments
19000000 usd
CY2022Q4 et Aoci Attributable To Equity Method Investments
AociAttributableToEquityMethodInvestments
13000000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
29000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
16000000 usd
CY2023Q3 et Contractual Rightof Way Expense
ContractualRightofWayExpense
20000000 usd
CY2022Q3 et Contractual Rightof Way Expense
ContractualRightofWayExpense
16000000 usd
et Contractual Rightof Way Expense
ContractualRightofWayExpense
46000000 usd
et Contractual Rightof Way Expense
ContractualRightofWayExpense
44000000 usd
CY2023Q3 us-gaap Loss Contingency Range Of Possible Loss Portion Not Accrued
LossContingencyRangeOfPossibleLossPortionNotAccrued
200000000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
161000000 usd
et Interest Statutory Rate
InterestStatutoryRate
0.12 rate
CY2023Q3 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
44000000 usd
CY2022Q4 us-gaap Accrued Environmental Loss Contingencies Current
AccruedEnvironmentalLossContingenciesCurrent
54000000 usd
CY2023Q3 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
240000000 usd
CY2022Q4 us-gaap Accrued Environmental Loss Contingencies Noncurrent
AccruedEnvironmentalLossContingenciesNoncurrent
228000000 usd
CY2023Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
284000000 usd
CY2022Q4 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
282000000 usd
us-gaap Payments For Environmental Liabilities
PaymentsForEnvironmentalLiabilities
23000000 usd
us-gaap Payments For Environmental Liabilities
PaymentsForEnvironmentalLiabilities
8000000 usd
CY2023Q3 us-gaap Revenues
Revenues
20739000000 usd
CY2022Q3 us-gaap Revenues
Revenues
22939000000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
615000000 usd
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
794000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-836000000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
573000000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
459000000 usd
us-gaap Deferred Revenue Additions
DeferredRevenueAdditions
815000000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-688000000 usd
us-gaap Deferred Revenue Period Increase Decrease
DeferredRevenuePeriodIncreaseDecrease
-13000000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
573000000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
39830000000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Year1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionYear1
2023
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Year1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionYear1
2024
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Year1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionYear1
2025
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2176000000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
7345000000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
6247000000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
24062000000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
39830000000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Risk</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk refers to the risk that a counterparty may default on its contractual obligations, resulting in a loss to the Partnership. Credit policies have been approved and implemented to govern the Partnership’s portfolio of counterparties with the objective of mitigating credit losses. These policies establish guidelines, controls and limits to manage credit risk within approved tolerances by mandating an appropriate evaluation of the financial condition of existing and potential counterparties, monitoring agency credit ratings, and by implementing credit practices that limit exposure according to the risk profiles of the counterparties. Furthermore, the Partnership may, at times, require collateral under certain circumstances to mitigate credit risk as necessary. The Partnership also uses industry standard commercial agreements which allow for the netting of exposures associated with transactions executed under a single commercial agreement. Additionally, we utilize master netting agreements to offset credit exposure across multiple commercial agreements with a single counterparty or affiliated group of counterparties.</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our natural gas transportation and midstream revenues are derived significantly from companies that engage in exploration and production activities. In addition to oil and gas producers, the Partnership’s counterparties consist of a diverse portfolio of customers across the energy industry, including petrochemical companies, commercial and industrial end-users, municipalities, gas and electric utilities, midstream companies and independent power generators. Our overall exposure may be affected positively or negatively by macroeconomic or regulatory changes that impact our counterparties to one extent or another. Currently, management does not anticipate a material adverse effect on our financial position or results of operations as a consequence of counterparty non-performance.</span></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Partnership has maintenance margin deposits with certain counterparties in the OTC market, primarily with independent system operators and with clearing brokers. Payments on margin deposits are required when the value of a derivative exceeds our pre-established credit limit with the counterparty. Margin deposits are returned to us on or about the settlement date for non-exchange traded derivatives, and we exchange margin calls on a daily basis for exchange traded transactions. Since the margin calls are made daily with the exchange brokers, the fair value of the financial derivative instruments are deemed current and netted in deposits paid to vendors within other current assets in the consolidated balance sheets. </span></div>For financial instruments, failure of a counterparty to perform on a contract could result in our inability to realize amounts that have been recorded on our consolidated balance sheets and recognized in net income or other comprehensive income.
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
419000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
688000000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
449000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
549000000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
419000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
688000000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
449000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
549000000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
49000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
244000000 usd
CY2023Q3 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
79000000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
105000000 usd
CY2023Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
32000000 usd
CY2022Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
60000000 usd
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
47000000 usd
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
303000000 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-130000000 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
268000000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-65000000 usd
us-gaap Revenues
Revenues
58054000000 usd
us-gaap Revenues
Revenues
69375000000 usd
CY2023Q3 et Segment Adjusted Ebitda
SegmentAdjustedEBITDA
3541000000 usd
CY2022Q3 et Segment Adjusted Ebitda
SegmentAdjustedEBITDA
3088000000 usd
et Segment Adjusted Ebitda
SegmentAdjustedEBITDA
10096000000 usd
et Segment Adjusted Ebitda
SegmentAdjustedEBITDA
9656000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
1047000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
1322000000 usd
us-gaap Profit Loss
ProfitLoss
3727000000 usd
us-gaap Profit Loss
ProfitLoss
4431000000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1107000000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1030000000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3227000000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3104000000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
632000000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
577000000 usd
us-gaap Interest Expense
InterestExpense
1892000000 usd
us-gaap Interest Expense
InterestExpense
1714000000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
77000000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
82000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
256000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
159000000 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1000000 usd
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
86000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
12000000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
386000000 usd
CY2023Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
32000000 usd
CY2022Q3 us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
60000000 usd
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
47000000 usd
us-gaap Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments
GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments
303000000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
35000000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
27000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
99000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
88000000 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
107000000 usd
CY2022Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-76000000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
182000000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-130000000 usd
CY2023Q3 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
-141000000 usd
CY2022Q3 us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
40000000 usd
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
-113000000 usd
us-gaap Inventory Lifo Reserve Period Charge
InventoryLIFOReservePeriodCharge
-81000000 usd
CY2023Q3 et Adjusted Ebitda Attributable To Unconsolidated Affiliates
AdjustedEbitdaAttributableToUnconsolidatedAffiliates
182000000 usd
CY2022Q3 et Adjusted Ebitda Attributable To Unconsolidated Affiliates
AdjustedEbitdaAttributableToUnconsolidatedAffiliates
147000000 usd
et Adjusted Ebitda Attributable To Unconsolidated Affiliates
AdjustedEbitdaAttributableToUnconsolidatedAffiliates
514000000 usd
et Adjusted Ebitda Attributable To Unconsolidated Affiliates
AdjustedEbitdaAttributableToUnconsolidatedAffiliates
409000000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
103000000 usd
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
68000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
286000000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
186000000 usd
CY2023Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-625000000 usd
CY2022Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-625000000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
CY2023Q3 et Other Net
OtherNet
4000000 usd
CY2022Q3 et Other Net
OtherNet
-19000000 usd
et Other Net
OtherNet
8000000 usd
et Other Net
OtherNet
65000000 usd
CY2023Q3 et Segment Adjusted Ebitda
SegmentAdjustedEBITDA
3541000000 usd
CY2022Q3 et Segment Adjusted Ebitda
SegmentAdjustedEBITDA
3088000000 usd
et Segment Adjusted Ebitda
SegmentAdjustedEBITDA
10096000000 usd
et Segment Adjusted Ebitda
SegmentAdjustedEBITDA
9656000000 usd

Files In Submission

Name View Source Status
0001276187-23-000093-index-headers.html Edgar Link pending
0001276187-23-000093-index.html Edgar Link pending
0001276187-23-000093.txt Edgar Link pending
0001276187-23-000093-xbrl.zip Edgar Link pending
et-20230930.htm Edgar Link pending
et-20230930.xsd Edgar Link pending
et-20230930_g1.jpg Edgar Link pending
et09-30x2023ex311.htm Edgar Link pending
et09-30x2023ex312.htm Edgar Link pending
et09-30x2023ex313.htm Edgar Link pending
et09-30x2023ex321.htm Edgar Link pending
et09-30x2023ex322.htm Edgar Link pending
et09-30x2023ex323.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
et-20230930_def.xml Edgar Link unprocessable
et-20230930_lab.xml Edgar Link unprocessable
et-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
et-20230930_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
et-20230930_pre.xml Edgar Link unprocessable